Berta Eszter
DE >
GYTKDepartment of Clinical Pharmacology
egyetemi tanársegéd 2012-2021
DE >
GYTKDepartment of Clinical Pharmacology
egyetemi adjunktus 2021-
Name: Berta Eszter
Affiliation: - Debreceni Egyetem. A DE Központi Egységei. Klinikai Központ. Belgyógyászati Klinika. A épület (Belgyógyászati Klinika) / University of Debrecen. Central Units of UD. Medical Center. Internal Medicine. A Building of Internal Medicine
- Debreceni Egyetem. Gyógyszerésztudományi Kar. Klinikai Farmakológiai Tanszék / University of Debrecen. Faculty of Pharmacy. Department of Clinical Pharmacology
Degree
- Ph.D., Debreceni Egyetem (2018)
Publication list
2022
Bak-Csiha, S.,
Halmi, S.,
Hutkai, D.,
Molnár, I.,
Katkó, M.,
Lőrincz, H.,
Harangi, M.,
Paragh, G.,
Nagy, E.,
Bodor, M.,
Berta, E.:
Association of chemerin and serum advanced glycation end products in patients with autoimmune thyroiditis.
EJEA. 81 EP400, 2022.
Lengyel, I.,
Halmi, S.,
Lőrincz, H.,
Bak-Csiha, S.,
Katkó, M.,
Harangi, M.,
Nagy, E.,
Paragh, G.,
Bodor, M.,
Berta, E.:
Characterization of fetuin-A levels in patients with autoimmune thyroid disease.
Atherosclerosis. 355 e247-e248, 2022.
Berta, E.,
Zsíros, N.,
Bodor, M.,
Balogh, I.,
Lőrincz, H.,
Paragh, G.,
Harangi, M.:
Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia.
Genes. 13 (7), 1-19, 2022.
Journal metrics:
Q2 Genetics (2021)
Q2 Genetics (clinical) (2021)
Erdei, A.,
Gazdag, A.,
Ujhelyi, B.,
Nagy, E.,
Berényi, E.,
Berta, E.,
Steiber, Z.,
Barna, S.,
Mezősi, E.,
Bodor, M.,
Nagy, E.:
Non-surgical orbital decompression using diuresis in dysthyroid optic neuropathy: a case report.
Eur. Thyroid J. 11 (5), 1-10, 2022.
Journal metrics:
Q1 Endocrinology, Diabetes and Metabolism (2021)
Berta, E.,
Lengyel, I.,
Hegedűs, L.,
Papini, E.,
Perros, P.,
Negro, R.,
Attanasio, R.,
Nagy, E.,
Bodor, M.:
Pajzsmirigyhormon-kezelési szokások Magyarországon.
Orv. hetil. 163 (12), 463-472, 2022.
Journal metrics:
Q4 Medicine (miscellaneous) (2021)
Katkó, M.,
Gazdag, A.,
Harangi, M.,
Szentpéteri, A.,
Galgóczi, E.,
Erdei, A.,
Berta, E.,
Bodor, M.,
Bhattoa, H.,
Nagy, E.:
The effect of iatrogenic hypothyroidism on lipoprotein subfractions and serum paraoxonase activity in patients with differentiated thyroid cancer.
Atherosclerosis. 355 e163, 2022.
2021
Berta, E.,
Bodor, M.,
Halmi, S.,
Lengyel, I.,
Diószegi, Á.,
Katkó, M.,
Seres, I.,
Nagy, E.,
Paragh, G.,
Harangi, M.:
Strong correlations between serum fibroblast growth factor 21 level and lipid parameters in patients with autoimmune thyroiditis.
Atherosclerosis. 331 e201, 2021.
Katkó, M.,
Galgóczi, E.,
Erdei, A.,
Gazdag, A.,
Berta, E.,
Bodor, M.,
Seres, I.,
Hircsu, I.,
Badics, Á.,
Ujhelyi, B.,
Sira, L.,
Bhattoa, H.,
Nagy, E.:
The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease.
J. Inflamm. Res. 14 1883-1890, 2021.
Journal metrics:
Q2 Immunology
Q2 Immunology and Allergy
2020
Hircsu, I.,
Gazdag, A.,
Bodor, M.,
Berta, E.,
Andrási, M.,
Kanyári, Z.,
Győry, F.,
Barna, S.,
Bhattoa, H.,
Nagy, B.,
Nagy, E.,
Erdei, A.:
A multiplex endokrin neoplasia-2A szindrómáról egy család kapcsán.
Orv. hetil. 161 (2), 75-79, 2020.
Journal metrics:
Q4 Medicine (miscellaneous)
Galgóczi, E.,
Jeney, F.,
Katkó, M.,
Erdei, A.,
Gazdag, A.,
Sira, L.,
Bodor, M.,
Berta, E.,
Ujhelyi, B.,
Steiber, Z.,
Győry, F.,
Nagy, E.:
Characteristics of Hyaluronan Synthesis Inhibition by 4-Methylumbelliferone in Orbital Fibroblasts.
Invest. Ophthalmol. Vis. Sci. 61 (2), 27-, 2020.
Journal metrics:
Q1 Cellular and Molecular Neuroscience
D1 Ophthalmology
Q1 Sensory Systems
2019
Kovács, D.,
Fedor, R.,
Andrási, M.,
Barna, S.,
Tóth, L.,
Berta, E.,
Furka, A.,
Pászti, E.,
Damjanovich, L.,
Győry, F.:
A differenciálatlan pajzsmirigy-carcinoma szupportív kezelésének kihívásai 3 eset bemutatása kapcsán.
Magyar Seb. 72 (3), 135, 2019.
Berta, E.,
Lengyel, I.,
Halmi, S.,
Zrínyi, M.,
Erdei, A.,
Harangi, M.,
Páll, D.,
Nagy, E.,
Bodor, M.:
Hypertension in thyroid disorders.
Front Endocrinol (Lausanne). 10 1-11, 2019.
Journal metrics:
Q1 Endocrinology, Diabetes and Metabolism
2018
Berta, E.,
Bodor, M.,
Galuska, L.,
Paragh, G.,
Erdei, A.,
Gazdag, A.,
Ujhelyi, B.,
Berényi, E.,
Katkó, M.,
Gazsó, A.,
Nagy, E.:
Early stage Graves' disease is uniformly accompanied by orbital immune activity even in patients who fail to develop orbithopathy during follow-up.
Exp. Clin. Endocrinol. Diabet. 126 (10), 628-631, 2018.
Journal metrics:
Q3 Endocrinology
Q3 Endocrinology, Diabetes and Metabolism
Q2 Internal Medicine
Q2 Medicine (miscellaneous)
2016
Erdei, A.,
Steiber, Z.,
Gazdag, A.,
Bodor, M.,
Berta, E.,
Szász, R.,
Szántó, A.,
Ujhelyi, B.,
Barna, S.,
Berényi, E.,
Nagy, E.:
Az endokrin orbitopathia differenciáldiagnosztikája.
Orvosi Hetilap. 157 (8), 310-315, 2016.
Journal metrics:
Q4 Medicine (miscellaneous)
Galgóczi, E.,
Jeney, F.,
Gazdag, A.,
Erdei, A.,
Katkó, M.,
M. Nagy, D.,
Ujhelyi, B.,
Steiber, Z.,
Győry, F.,
Berta, E.,
Nagy, E.:
Cell density dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-[béta] in orbital fibroblasts.
J. Endocrinol. 229 (2), 187-196, 2016.
Journal metrics:
Q1 Endocrinology
D1 Endocrinology, Diabetes and Metabolism
Berta, E.,
Harangi, M.,
Varga, V.,
Lórincz, H.,
Seres, I.,
Nagy, E.,
Paragh, G.,
Bodor, M.:
Evaluation of serum chemerin level in patients with Hashimoto's thyroiditis.
Atherosclerosis. 252 e168, 2016.
2015
Gazdag, A.,
Nagy, E.,
Erdei, A.,
Bodor, M.,
Berta, E.,
Szabó, Z.,
Jenei, Z.:
Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer.
J. Endocrinol. Invest. 38 (2), 133-142, 2015.
Journal metrics:
Q3 Endocrinology
Q3 Endocrinology, Diabetes and Metabolism
Berta, E.,
Harangi, M.,
Zsíros, N.,
Nagy, E.,
Paragh, G.,
Bodor, M.:
Relation between thyroid hormone status and concomitant medication in hyperlipidaemic patients with statin induced adverse effects.
Endocrine abstracts. 37 EP592, 2015.
Berta, E.,
Ujhelyi, B.,
Szabados, L.,
Galuska, L.,
Erdei, A.,
Gazdag, A.,
Halmi, S.,
Nagy, E.,
Bodor, M.:
There is a detectable immune activity in the orbits of all patients diagnosed with Graves' regardless of later development of Graves' orbitopathy.
Endocrine Abstracts. 37 GP, 2015.
2014
Berta, E.,
Harangi, M.,
Zsíros, N.,
Nagy, E.,
Paragh, G.,
Bodor, M.:
A gyógyszerkölcsönhatások és a kóros pajzsmirigyhormon-státusz vizsgálata sztatinnal kezelt hyperlipidaemiás betegekben.
Magyar Belorv. Arch. Suppl. 67 406-411, 2014.
Zsíros, N.,
Dunás-Varga, V.,
Bodor, M.,
Berta, E.,
Balogh, I.,
Seres, I.,
Paragh, G.,
Harangi, M.:
Effect of the -133 A>G NPC1L1 gene polymorphism on the efficacy of ezetimibe monotherapy.
Atherosclerosis. 235 (2), e75, 2014.
Berta, E.,
Harangi, M.,
Zsíros, N.,
Nagy, E.,
Paragh, G.,
Bodor, M.:
Effect of thyroid hormone status and concomitant medication on statin induced adverse effects in hyperlipidemic patients.
Pharmazie. 69 420-423, 2014.
Journal metrics:
Q2 Pharmaceutical Science
Molnár, Z.,
Berta, E.,
Benyó, M.,
Póka, R.,
Bazsáné Kassai, Z.,
Flaskó, T.,
Jakab, A.,
Bodor, M.:
Fertility of testicular cancer patients after anticancer treatment: experience of 11 years.
Pharmazie. 69 (6), 437-441, 2014.
Journal metrics:
Q2 Pharmaceutical Science
Erdei, A.,
Paragh, G.,
Kovács, P.,
Karányi, Z.,
Berényi, E.,
Galuska, L.,
Lenkey, Á.,
Szabados, L.,
Győry, F.,
Ujhelyi, B.,
Berta, A.,
Boda, J.,
Berta, E.,
Bodor, M.,
Gazdag, A.,
Nagy, E.:
Rapid response to and long-term effectiveness of anti-CD20 antibody in conventional therapy resistant Graves' orbitopathy: a five-year follow-up study.
Autoimmunity. 47 (8), 548-555, 2014.
Journal metrics:
Q3 Immunology
Q3 Immunology and Allergy
Harangi, M.,
Berta, E.,
Zsíros, N.,
Paragh, G.,
Nagy, E.,
Bodor, M.:
Thyroid hormone status and concomitant medication in hyperlipidemic patients with statin induced adverse effects.
Atherosclerosis. 235 (2), e255, 2014.
2022
Bak-Csiha, S.,
Halmi, S.,
Hutkai, D.,
Molnár, I.,
Katkó, M.,
Lőrincz, H.,
Harangi, M.,
Paragh, G.,
Nagy, E.,
Bodor, M.,
Berta, E.:
Association of chemerin and serum advanced glycation end products in patients with autoimmune thyroiditis.
EJEA. 81 EP400, 2022.
Lengyel, I.,
Halmi, S.,
Lőrincz, H.,
Bak-Csiha, S.,
Katkó, M.,
Harangi, M.,
Nagy, E.,
Paragh, G.,
Bodor, M.,
Berta, E.:
Characterization of fetuin-A levels in patients with autoimmune thyroid disease.
Atherosclerosis. 355 e247-e248, 2022.
Berta, E.,
Zsíros, N.,
Bodor, M.,
Balogh, I.,
Lőrincz, H.,
Paragh, G.,
Harangi, M.:
Clinical Aspects of Genetic and Non-Genetic Cardiovascular Risk Factors in Familial Hypercholesterolemia.
Genes. 13 (7), 1-19, 2022.
Journal metrics:
Q2 Genetics (2021)
Q2 Genetics (clinical) (2021)
Erdei, A.,
Gazdag, A.,
Ujhelyi, B.,
Nagy, E.,
Berényi, E.,
Berta, E.,
Steiber, Z.,
Barna, S.,
Mezősi, E.,
Bodor, M.,
Nagy, E.:
Non-surgical orbital decompression using diuresis in dysthyroid optic neuropathy: a case report.
Eur. Thyroid J. 11 (5), 1-10, 2022.
Journal metrics:
Q1 Endocrinology, Diabetes and Metabolism (2021)
Berta, E.,
Lengyel, I.,
Hegedűs, L.,
Papini, E.,
Perros, P.,
Negro, R.,
Attanasio, R.,
Nagy, E.,
Bodor, M.:
Pajzsmirigyhormon-kezelési szokások Magyarországon.
Orv. hetil. 163 (12), 463-472, 2022.
Journal metrics:
Q4 Medicine (miscellaneous) (2021)
Katkó, M.,
Gazdag, A.,
Harangi, M.,
Szentpéteri, A.,
Galgóczi, E.,
Erdei, A.,
Berta, E.,
Bodor, M.,
Bhattoa, H.,
Nagy, E.:
The effect of iatrogenic hypothyroidism on lipoprotein subfractions and serum paraoxonase activity in patients with differentiated thyroid cancer.
Atherosclerosis. 355 e163, 2022.
2021
Berta, E.,
Bodor, M.,
Halmi, S.,
Lengyel, I.,
Diószegi, Á.,
Katkó, M.,
Seres, I.,
Nagy, E.,
Paragh, G.,
Harangi, M.:
Strong correlations between serum fibroblast growth factor 21 level and lipid parameters in patients with autoimmune thyroiditis.
Atherosclerosis. 331 e201, 2021.
Katkó, M.,
Galgóczi, E.,
Erdei, A.,
Gazdag, A.,
Berta, E.,
Bodor, M.,
Seres, I.,
Hircsu, I.,
Badics, Á.,
Ujhelyi, B.,
Sira, L.,
Bhattoa, H.,
Nagy, E.:
The 4G/5G Polymorphism of Plasminogen Activator Inhibitor Type 1 is a Predictor of Moderate-to-Severe Thyroid Eye Disease.
J. Inflamm. Res. 14 1883-1890, 2021.
Journal metrics:
Q2 Immunology
Q2 Immunology and Allergy
2020
Hircsu, I.,
Gazdag, A.,
Bodor, M.,
Berta, E.,
Andrási, M.,
Kanyári, Z.,
Győry, F.,
Barna, S.,
Bhattoa, H.,
Nagy, B.,
Nagy, E.,
Erdei, A.:
A multiplex endokrin neoplasia-2A szindrómáról egy család kapcsán.
Orv. hetil. 161 (2), 75-79, 2020.
Journal metrics:
Q4 Medicine (miscellaneous)
Galgóczi, E.,
Jeney, F.,
Katkó, M.,
Erdei, A.,
Gazdag, A.,
Sira, L.,
Bodor, M.,
Berta, E.,
Ujhelyi, B.,
Steiber, Z.,
Győry, F.,
Nagy, E.:
Characteristics of Hyaluronan Synthesis Inhibition by 4-Methylumbelliferone in Orbital Fibroblasts.
Invest. Ophthalmol. Vis. Sci. 61 (2), 27-, 2020.
Journal metrics:
Q1 Cellular and Molecular Neuroscience
D1 Ophthalmology
Q1 Sensory Systems
2019
Kovács, D.,
Fedor, R.,
Andrási, M.,
Barna, S.,
Tóth, L.,
Berta, E.,
Furka, A.,
Pászti, E.,
Damjanovich, L.,
Győry, F.:
A differenciálatlan pajzsmirigy-carcinoma szupportív kezelésének kihívásai 3 eset bemutatása kapcsán.
Magyar Seb. 72 (3), 135, 2019.
Berta, E.,
Lengyel, I.,
Halmi, S.,
Zrínyi, M.,
Erdei, A.,
Harangi, M.,
Páll, D.,
Nagy, E.,
Bodor, M.:
Hypertension in thyroid disorders.
Front Endocrinol (Lausanne). 10 1-11, 2019.
Journal metrics:
Q1 Endocrinology, Diabetes and Metabolism
2018
Berta, E.,
Bodor, M.,
Galuska, L.,
Paragh, G.,
Erdei, A.,
Gazdag, A.,
Ujhelyi, B.,
Berényi, E.,
Katkó, M.,
Gazsó, A.,
Nagy, E.:
Early stage Graves' disease is uniformly accompanied by orbital immune activity even in patients who fail to develop orbithopathy during follow-up.
Exp. Clin. Endocrinol. Diabet. 126 (10), 628-631, 2018.
Journal metrics:
Q3 Endocrinology
Q3 Endocrinology, Diabetes and Metabolism
Q2 Internal Medicine
Q2 Medicine (miscellaneous)
2016
Erdei, A.,
Steiber, Z.,
Gazdag, A.,
Bodor, M.,
Berta, E.,
Szász, R.,
Szántó, A.,
Ujhelyi, B.,
Barna, S.,
Berényi, E.,
Nagy, E.:
Az endokrin orbitopathia differenciáldiagnosztikája.
Orvosi Hetilap. 157 (8), 310-315, 2016.
Journal metrics:
Q4 Medicine (miscellaneous)
Galgóczi, E.,
Jeney, F.,
Gazdag, A.,
Erdei, A.,
Katkó, M.,
M. Nagy, D.,
Ujhelyi, B.,
Steiber, Z.,
Győry, F.,
Berta, E.,
Nagy, E.:
Cell density dependent stimulation of PAI-1 and hyaluronan synthesis by TGF-[béta] in orbital fibroblasts.
J. Endocrinol. 229 (2), 187-196, 2016.
Journal metrics:
Q1 Endocrinology
D1 Endocrinology, Diabetes and Metabolism
Berta, E.,
Harangi, M.,
Varga, V.,
Lórincz, H.,
Seres, I.,
Nagy, E.,
Paragh, G.,
Bodor, M.:
Evaluation of serum chemerin level in patients with Hashimoto's thyroiditis.
Atherosclerosis. 252 e168, 2016.
2015
Gazdag, A.,
Nagy, E.,
Erdei, A.,
Bodor, M.,
Berta, E.,
Szabó, Z.,
Jenei, Z.:
Aortic stiffness and left ventricular function in patients with differentiated thyroid cancer.
J. Endocrinol. Invest. 38 (2), 133-142, 2015.
Journal metrics:
Q3 Endocrinology
Q3 Endocrinology, Diabetes and Metabolism
Berta, E.,
Harangi, M.,
Zsíros, N.,
Nagy, E.,
Paragh, G.,
Bodor, M.:
Relation between thyroid hormone status and concomitant medication in hyperlipidaemic patients with statin induced adverse effects.
Endocrine abstracts. 37 EP592, 2015.
Berta, E.,
Ujhelyi, B.,
Szabados, L.,
Galuska, L.,
Erdei, A.,
Gazdag, A.,
Halmi, S.,
Nagy, E.,
Bodor, M.:
There is a detectable immune activity in the orbits of all patients diagnosed with Graves' regardless of later development of Graves' orbitopathy.
Endocrine Abstracts. 37 GP, 2015.
2014
Berta, E.,
Harangi, M.,
Zsíros, N.,
Nagy, E.,
Paragh, G.,
Bodor, M.:
A gyógyszerkölcsönhatások és a kóros pajzsmirigyhormon-státusz vizsgálata sztatinnal kezelt hyperlipidaemiás betegekben.
Magyar Belorv. Arch. Suppl. 67 406-411, 2014.
Zsíros, N.,
Dunás-Varga, V.,
Bodor, M.,
Berta, E.,
Balogh, I.,
Seres, I.,
Paragh, G.,
Harangi, M.:
Effect of the -133 A>G NPC1L1 gene polymorphism on the efficacy of ezetimibe monotherapy.
Atherosclerosis. 235 (2), e75, 2014.
Berta, E.,
Harangi, M.,
Zsíros, N.,
Nagy, E.,
Paragh, G.,
Bodor, M.:
Effect of thyroid hormone status and concomitant medication on statin induced adverse effects in hyperlipidemic patients.
Pharmazie. 69 420-423, 2014.
Journal metrics:
Q2 Pharmaceutical Science
Molnár, Z.,
Berta, E.,
Benyó, M.,
Póka, R.,
Bazsáné Kassai, Z.,
Flaskó, T.,
Jakab, A.,
Bodor, M.:
Fertility of testicular cancer patients after anticancer treatment: experience of 11 years.
Pharmazie. 69 (6), 437-441, 2014.
Journal metrics:
Q2 Pharmaceutical Science
Erdei, A.,
Paragh, G.,
Kovács, P.,
Karányi, Z.,
Berényi, E.,
Galuska, L.,
Lenkey, Á.,
Szabados, L.,
Győry, F.,
Ujhelyi, B.,
Berta, A.,
Boda, J.,
Berta, E.,
Bodor, M.,
Gazdag, A.,
Nagy, E.:
Rapid response to and long-term effectiveness of anti-CD20 antibody in conventional therapy resistant Graves' orbitopathy: a five-year follow-up study.
Autoimmunity. 47 (8), 548-555, 2014.
Journal metrics:
Q3 Immunology
Q3 Immunology and Allergy
Harangi, M.,
Berta, E.,
Zsíros, N.,
Paragh, G.,
Nagy, E.,
Bodor, M.:
Thyroid hormone status and concomitant medication in hyperlipidemic patients with statin induced adverse effects.
Atherosclerosis. 235 (2), e255, 2014.
Erdei, A.,
Gazdag, A.,
Bodor, M.,
Berta, E.,
Katkó, M.,
Ujhelyi, B.,
Steiber, Z.,
Győry, F.,
Urbancsek, H.,
Barna, S.,
Galuska, L.,
Nagy, E.:
Új lehetőségek az endokrin orbitopathia kezelésében.
Orvosi Hetilap. 155 (33), 1295-1300, 2014.
Journal metrics:
Q3 Medicine (miscellaneous)
2012
Berta, E.,
Erdei, A.,
Cseke, B.,
Gazdag, A.,
Paragh, G.,
Balla, J.,
Polgár, P.,
Nagy, E.,
Bodor, M.:
Evaluation of the metabolic changes during hemodialysis by signal averaged ECG.
Pharmazie. 67 (5), 380-383, 2012.
Journal metrics:
Q2 Pharmaceutical Science
2010
Berta, E.,
Sámson, L.,
Lenkey, Á.,
Erdei, A.,
Cseke, B.,
Jenei, K.,
Major, T.,
Jakab, A.,
Jenei, Z.,
Paragh, G.,
Nagy, E.,
Bodor, M.:
Evaluation of the thyroid function of healthy pregnant women by five different hormone assays.
Pharmazie. 65 (6), 436-439, 2010.
Journal metrics:
Q2 Pharmaceutical Science
2006
Bodor, M.,
Erdei, A.,
Balla, J.,
Berta, E.,
Paragh, G.,
Polgár, P.,
Nagy, E.:
Krónikus hemodialízis programban lévő betegek jelátlagolt EKG-vizsgálata.
É-K. Magyarorsz. Orv. Szle. 7 (1-2), 26-31, 2006.
Show all
updated: 2023-03-19, 01:08
